More rTMS pulses or more sessions? The impact on treatment outcome for treatment resistant depression.

IF 5.3 2区 医学 Q1 PSYCHIATRY Acta Psychiatrica Scandinavica Pub Date : 2024-11-21 DOI:10.1111/acps.13768
E Oostra, P Jazdzyk, V Vis, I Dalhuisen, A W Hoogendoorn, C H M Planting, P F van Eijndhoven, Y D van der Werf, O A van den Heuvel, E van Exel
{"title":"More rTMS pulses or more sessions? The impact on treatment outcome for treatment resistant depression.","authors":"E Oostra, P Jazdzyk, V Vis, I Dalhuisen, A W Hoogendoorn, C H M Planting, P F van Eijndhoven, Y D van der Werf, O A van den Heuvel, E van Exel","doi":"10.1111/acps.13768","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Repetitive transcranial magnetic stimulation (rTMS) is effective for treatment-resistant depression (TRD). Optimal rTMS parameters remain unclear, especially whether number of sessions or amount of pulses contribute more to treatment outcome. We hypothesize that treatment outcome depends on the number of sessions rather than on the amount of pulses.</p><p><strong>Methods: </strong>We searched databases for randomized clinical trials (RCTs) on high-frequent (HF) or low-frequent (LF)-rTMS targeting the left or right DLPFC for TRD. Treatment efficacy was measured using standardized mean difference (SMD), calculated from pre- and post-treatment depression scores. Meta-regressions were used to explore linear associations between SMD and rTMS pulses, pulses/session and sessions for HF and LF-rTMS, separately for active and sham-rTMS. If these variables showed no linear association with SMD, we divided the data into quartiles and explored subgroup SMDs.</p><p><strong>Results: </strong>Eighty-seven RCTs were included: 67 studied HF-rTMS, eleven studied LF-rTMS, and nine studied both. No linear association was found between SMD and amount of pulses or pulses/session for HF and LF-rTMS. Subgroup analyses showed the largest SMDs for 1200-1500 HF-pulses/session and 360-450 LF-pulses/session. The number of sessions was significantly associated with SMD for active HF (β = 0.09, p < 0.05) and LF-rTMS (β = 0.06, p < 0.01). Thirty was the maximal number of sessions, in the included RCTs.</p><p><strong>Conclusion: </strong>More rTMS sessions, but not more pulses, were associated with improved treatment outcome, in both HF and LF-rTMS. Our findings suggest that 1200-1500 HF-pulses/session and 360-450 LF-pulses/session are already sufficient, and that a treatment course should consist of least 30 sessions for higher chance of response.</p>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Psychiatrica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/acps.13768","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Repetitive transcranial magnetic stimulation (rTMS) is effective for treatment-resistant depression (TRD). Optimal rTMS parameters remain unclear, especially whether number of sessions or amount of pulses contribute more to treatment outcome. We hypothesize that treatment outcome depends on the number of sessions rather than on the amount of pulses.

Methods: We searched databases for randomized clinical trials (RCTs) on high-frequent (HF) or low-frequent (LF)-rTMS targeting the left or right DLPFC for TRD. Treatment efficacy was measured using standardized mean difference (SMD), calculated from pre- and post-treatment depression scores. Meta-regressions were used to explore linear associations between SMD and rTMS pulses, pulses/session and sessions for HF and LF-rTMS, separately for active and sham-rTMS. If these variables showed no linear association with SMD, we divided the data into quartiles and explored subgroup SMDs.

Results: Eighty-seven RCTs were included: 67 studied HF-rTMS, eleven studied LF-rTMS, and nine studied both. No linear association was found between SMD and amount of pulses or pulses/session for HF and LF-rTMS. Subgroup analyses showed the largest SMDs for 1200-1500 HF-pulses/session and 360-450 LF-pulses/session. The number of sessions was significantly associated with SMD for active HF (β = 0.09, p < 0.05) and LF-rTMS (β = 0.06, p < 0.01). Thirty was the maximal number of sessions, in the included RCTs.

Conclusion: More rTMS sessions, but not more pulses, were associated with improved treatment outcome, in both HF and LF-rTMS. Our findings suggest that 1200-1500 HF-pulses/session and 360-450 LF-pulses/session are already sufficient, and that a treatment course should consist of least 30 sessions for higher chance of response.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
更多经颅磁刺激脉冲还是更多疗程?对抗药性抑郁症治疗效果的影响。
背景:重复经颅磁刺激(rTMS)对治疗抵抗性抑郁症(TRD)有效。最佳经颅磁刺激参数仍不明确,尤其是治疗次数或脉冲量对治疗效果的影响更大。我们假设治疗效果取决于治疗次数而非脉冲量:我们在数据库中搜索了针对左侧或右侧DLPFC的高频(HF)或低频(LF)经颅磁刺激治疗TRD的随机临床试验(RCT)。根据治疗前后的抑郁评分计算出的标准化平均差(SMD)来衡量疗效。元回归用于探讨SMD与高频和低频经颅磁刺激脉冲、脉冲/疗程以及疗程之间的线性关系,并分别用于主动和假经颅磁刺激。如果这些变量没有显示出与SMD的线性关系,我们将数据分为四等分,并探讨亚组SMD:结果:共纳入 87 项 RCT:67项研究了高频经颅磁刺激(HF-rTMS),11项研究了低频经颅磁刺激(LF-rTMS),9项研究了两者。在高频经颅磁刺激和低频经颅磁刺激的SMD与脉冲数或脉冲/疗程之间未发现线性关系。分组分析显示,1200-1500 高频脉冲/次和 360-450 低频脉冲/次的 SMD 最大。治疗次数与活动性高频的 SMD 显著相关(β = 0.09,p 结论:治疗次数越多,SMD 越大:在高频和低频经颅磁刺激中,更多的经颅磁刺激疗程(而非更多的脉冲)与治疗效果的改善相关。我们的研究结果表明,1200-1500 次高频脉冲/疗程和 360-450 次低频脉冲/疗程已经足够,治疗疗程至少应为 30 次,这样才有可能获得更高的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Psychiatrica Scandinavica
Acta Psychiatrica Scandinavica 医学-精神病学
CiteScore
11.20
自引率
3.00%
发文量
135
审稿时长
6-12 weeks
期刊介绍: Acta Psychiatrica Scandinavica acts as an international forum for the dissemination of information advancing the science and practice of psychiatry. In particular we focus on communicating frontline research to clinical psychiatrists and psychiatric researchers. Acta Psychiatrica Scandinavica has traditionally been and remains a journal focusing predominantly on clinical psychiatry, but translational psychiatry is a topic of growing importance to our readers. Therefore, the journal welcomes submission of manuscripts based on both clinical- and more translational (e.g. preclinical and epidemiological) research. When preparing manuscripts based on translational studies for submission to Acta Psychiatrica Scandinavica, the authors should place emphasis on the clinical significance of the research question and the findings. Manuscripts based solely on preclinical research (e.g. animal models) are normally not considered for publication in the Journal.
期刊最新文献
More rTMS pulses or more sessions? The impact on treatment outcome for treatment resistant depression. Letter to the Editor Concerning "Glucagon-Like Peptide Agonists for Weight Management in Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis". Prediction of electroconvulsive therapy outcome: A network analysis approach. How to treat antipsychotic-related weight gain and metabolic disturbances: Is there a role for GLP-1 receptor agonists? Issue Information
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1